We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: Histopathology of pulmonary adenocarcinoma with prominent signet-ring cell features (Photo courtesy of Cesar A. Moran, MD).

Potential Lung Cancer Blood Biomarker Found

Patients with non-small-cell lung cancer have different profiles of metabolites in their blood, suggesting there is a way to diagnose the disease from a blood sample.  More...
04 Nov 2014
Image: Classical type papillary thyroid carcinoma (Photo courtesy of University of Michigan Comprehensive Cancer Center).

Genomic Researchers Propose Reclassifying Thyroid Cancers into Molecular Subtypes

A recent paper detailed the comprehensive genomic characterization of papillary thyroid carcinoma, the most common type of thyroid cancer, and suggested reclassifying thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties. More...
03 Nov 2014
Image: Immunohistochemical staining of ovarian tissue with anti-CA125 for the diagnosis of ovarian carcinoma; the neoplastic cells are strongly stained (Photo courtesy of Epitomics).

Test Model Discriminates Ovarian Tumors

A new test can discriminate between benign and malignant ovarian tumors, and identify different types of carcinomatous tumors, with a high level of accuracy.  More...
28 Oct 2014
Image: Immunofluorescence staining pattern of ANCA using FITC conjugate demonstrates presence of antineutrophil cytoplasmic antibodies (ANCA). Top left - PR3 antibodies on ethanol-fixed neutrophils showing a cytoplasmic ANCA pattern. Bottom left - PR3 antibodies on formalin-fixed neutrophils showing a cytoplasmic ANCA pattern. Top right - MPO antibodies on ethanol-fixed neutrophils showing a perinuclear ANCA pattern. Bottom right - MPO antibodies on formalin-fixed neutrophils showing a cytoplasmic ANCA pattern (Photo courtesy of Wikimedia Commons).

Monitoring ANCA Levels Helps Predict Relapse of Systemic Vasculitis in Patients with Kidney Involvement

Repeated measurement of levels of anti-neutrophil cytoplasmic antibodies predicts likelihood of relapse in patients suffering from systemic vasculitis with kidney involvement.  More...
28 Oct 2014
Image: Histopathology of prostatic acinar adenocarcinoma, the most common form of prostate cancer, Gleason pattern 4, from prostate curettings (Photo courtesy of Nephron).

Protein-Based Test Improves Prognostic Accuracy for Prostate Cancer

A protein-based biopsy test has been designed to improve the accuracy of prognosis for men diagnosed with prostate cancer and can help identify the aggressiveness of the disease.   More...
27 Oct 2014

Prostate Cancer Specific RNAs Identified in Urine and Tissue

Researchers have discovered a set of potential-biomarker RNAs that may pave the way to a more reliable prostate cancer screening assay.  More...
27 Oct 2014
Image: Tumor cell populations identified using digital image analysis from a stained pathology slide, with the tumor regions detected and now colored orange (Photo courtesy of Definiens).

Biomarker Reveals Cause of Papillary Thyroid Carcinoma

The expression of the CAP-GLY domain containing linker protein 2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin.  More...
26 Oct 2014
Visit expo >
Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

In Other News



The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000 - 2024 Globetech Media.
All rights reserved.